Title | Geography | Industry | ||||
---|---|---|---|---|---|---|
Number of ongoing Clinical Trials (for drugs) involving Atherosclerosis by Phase | Other Industry Indicators | Germany | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Stroke by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Hypertension by Phase | Other Industry Indicators | Russia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Pulmonary Hypertension by Phase | Other Industry Indicators | Italy | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Hypertrophic Cardiomyopathy by Phase | Other Industry Indicators | Australia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Pulmonary Arterial Hypertension by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Pulmonary Embolism by Phase | Other Industry Indicators | United Kingdom | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Atrial Fibrillation by Phase | Other Industry Indicators | Netherlands | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Cardiovascular by Phase | Other Industry Indicators | Russia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Cardiomyopathy by Phase | Other Industry Indicators | Switzerland | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Global Prevalence of Pulmonary Arterial Hypertension | Market Sizing & Shares | Global | Healthcare | Mar 2022 | ||
Number of ongoing Clinical Trials (for drugs) involving Coronary Stenosis by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Left Ventricular Dysfunction by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Dilated Cardiomyopathy by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Cerebral Vasospasm by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Hypoxemia by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Cutaneous Vascular Malformations by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Thrombotic Microangiopathy by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Atrial Septal Defect by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Cerebrovascular Disease by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Unstable Angina by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Hemorrhagic Shock by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Pulmonary Edema by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Low Cardiac Output Syndrome by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Anaphylactic Shock by Phase | Other Industry Indicators | Germany | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Subarachnoid Hemorrhage by Phase | Other Industry Indicators | Japan | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Abdominal Aortic Aneurysm by Phase | Other Industry Indicators | South Africa | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Heart Valve Disease by Phase | Other Industry Indicators | Indonesia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Chronic Stable Angina by Phase | Other Industry Indicators | Italy | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Critical Limb Ischemia by Phase | Other Industry Indicators | Greece | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Hepatic Veno-Occlusive Disease by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Cardiovascular Inflammation by Phase | Other Industry Indicators | Egypt | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Reperfusion Injury by Phase | Other Industry Indicators | United Kingdom | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Eisenmenger Syndrome by Phase | Other Industry Indicators | India | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Sick Sinus Syndromes by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Refractory Angina by Phase | Other Industry Indicators | Spain | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Endocarditis by Phase | Other Industry Indicators | Ukraine | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Portal Hypertension by Phase | Other Industry Indicators | United Kingdom | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Carotid Artery Stenosis by Phase | Other Industry Indicators | Netherlands | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Peripheral Artery Occlusive Disease (PAOD) by Phase | Other Industry Indicators | Germany | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Intracranial Artery Stenosis by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Ventricular Fibrillation by Phase | Other Industry Indicators | Belgium | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Cardiogenic Shock by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Bicuspid Aortic Valve Disease by Phase | Other Industry Indicators | Netherlands | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Valvular Cardiomyopathy by Phase | Other Industry Indicators | Japan | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Thromboembolic Disease by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Occlusive Coronary Artery Disease by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Myocardial Fibrosis by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Vasculitis by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 |
Still looking?
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Explorer
Access more premium companies when you subscribe to Explorer